About Fibronostics
Fibronostics is a private company based in Boca Raton, Florida. It has reported $7,614,941 raised in five offerings on Form D since March 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 26, 2026 | $1,150,932of $2.1M target | 7 | $164K | Debt, OptionsRule 506(b) | Form D ↗ |
| Oct 22, 2025 | Nov 6, 2025 | $2,238,373of $2.7M target | 9 | $248K | EquityRule 506(b) | Form D ↗ |
| Aug 19, 2025 | Sep 3, 2025 | $1,670,428of $2.5M target | 7 | $238K | Debt, OptionsRule 506(b) | Form D ↗ |
| May 12, 2025 | May 23, 2025 | $350,780of $1.0M target | 10 | $35,078 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jan 6, 2025 | Mar 13, 2025 | $2,204,428of $2.5M target | 11 | $200K | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $7,614,941 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Fibronostics's Form D filed Mar 26, 2026.
Earlier filings also listed Cassandra Davies (executive officer, last listed May 2025).